DYRK1A and Alzheimer disease: Our results indicate that Dyrk1 inhibition reduces tau phosphorylation only in the insoluble fraction; these findings are consistent with the observation that in human AD brains Dyrk1a is associated with tau in the sarkosyl‐insoluble fraction (Ferrer et al., 2005).